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L' e.ffet hyperglycgmiant de la phgnylhydrazone de l' acide pyrumque
Rdsumd. La phdnylhydrazone de l'aeide pyruvique, injeet6e chez le rat, a un effet hyperglyc6miant qui d6bute la 30gme minute et se termine 330minutes apr6s l'injection. Cette action est att6nu6e par ]'insuline et le tolbutamide. Les rats surr6nalectornis6s ne pr6sentent pas d'616vation significative de la glyc6mie apr6s l'injection de cette substance. Key-words : Pyruvie acid phenylhydrazone, blood glucose, insulin, tolbutamide, adrenalectomy.
Blutzuclcersteigerung dureh
During investigations carried out at our laboratory on the relationships between experimental diabetes and tryptophan, an increase in blood sugar levels was noticed in rats injected with phenylhydrazones of ketoacids. The hyperglycemic effect was more evident in normally fed than in starved animals, and was counteracted by insulin and tolbutamide.
The present paper discusses the effect of pyruvic acid phenylhydrazone on the blood sugar level of rats in various experimental conditions.
Material and Methods
Pyruvic acid phenylhydrazone (PPtI) was prepared by mixing pyruvic acid and phenylhydrazine hydrochloride according to the method of FISCH~a [1] . The compound was recrystallized twice from ethanol; its melting point was 192 ~ A 3% solution of PPH in water was prepared by adjustment to pH 7.8--8.0 with NaOIt; the solution was used immediately.
Male and female Wistar rats, weighing 300--350 g, were used either in the fed or the fasted state. PPtt was injected by the intraperitoneal or the intravenous route at doses varying from 450 to 550 mg/kg in two injections at 15 min interval. Glucose (800 mg/kg) was given orally between the two injections of PPH.
Insulin (Lilly) was injected subcutaneously (0.3 or 1.0 I.U. per animal) immediately after the first PPIt injection. Tolbutamide (200--300 mg/kg) was given orally, 15 or 90 min before PPH; the rats of this group were given a dose of 500 mg/kg PPIt.
Blood sugar curves were determined by collecting blood samples from the tail vein at 0, 30, 90, 150, 210, 330 mill after the second PPtI injection. Glucose was estimated with the SOMOGYI-NELsOSr method [5, 8] .
PPI-I was observed to react with the arsenomolybdate reagent of NELSON. In order to ascertain whether the reducing power in the blood of PPIl-treated rats was actually due to glucose, blood samples from these animals were deproteinized with the Somogyi reagent and the clear filtrate pretreated for 3 hours at 38 ~ with glucose-oxidase before adding the Nelson reagent; in this way the glucose was removed, allowing the estimation of the residual reducing power of blood [10] . A large portion, more than 90 percent, of the reducing power of the blood after PPI-I injection appeared to be actually due to true glucose, and less than 10 percen~ to PPII.
In some cases, liver glycogen was isolated by precipitation with ethanol from tissue hydrolysates in 30% potassium hydroxide, the precipitate being washed thoroughly with ethanol and hydrolyzed with 1 N sulphurie acid; glycogen was estimated by measuring the reducing power of the sulphuric acid-hydrolyzate.
Some experiments were performed on adrena]ectomized rats. Animals were operated and for the subsequent 8 days given the normal diet together with 0.9% solution of sodium chloride; they were then treated with PPI-I and glucose, and the blood sugar curve determined as for the normal animals. Another group of rats was operated, and for the subsequent 6 days given a high protein diet (25 ~o protein) together with 0.9% solution of sodium chloride; each rat then received 2 mg hydrocortisone, dissolved in 10 % ethanol and given in 4 intramuscular injections over a period of 3 hours. The animals were then submitted to the treatment with PPH and glucose.
Results
PPtI was well tolerated by all the rats. Slight traces of haemolysis were observed 5~ hours after the injection.
crease started 30 rain and lasted over 210 rain after PPtI injection.
At the same time, the liver glycogen content decreased markedly, from an average of 4.97• The data given in Table 2 demonstrate that insulin inhibited the hyperglycemic action of PPtI. The blood glucose level failed to increase in starved rats treated with glucose, PPtI and insulin.
Tolbutamide also reduced the PPH hyperglycemia, as shown by the data of Table 3 . Rats treated with tolbutamide, either 15 or 90 min before PPtI, showed a blood sugar increase less evident than that in the control rats: significant differences were attained only at 210 and 330 min after PPH.
PPH injected in adrenaleetomized rats induced an increase in blood glucose, which was however not sig- Data for each group expressed as the mean of tile blood glucose (mg/ml of blood) 4-standard deviation, with the number of rats in parentheses.
Significance: P=0.01-0.001 for a, b, c and P<0.001 for d compared with the corresponding non-treated group.
In Table 1 are given the blood sugar levels after intraperitoneal injection of PPH in normally fed and in starved rats, treated or not with glucose orally. PPH induced a definite increase in blood sugar, more evident in normally fed animals treated with glucose. The innificant when compared with controls. Data on both group of animals are put together for comparison in Table 4 .
Adrenalectomized rats supplemented with a high protein diet and treated with hydrocortisone, in order U. Bo~ro~I: I-Iyperglyeemie Effect of Pyruvic Acid Phenylhydrazone Diabetologia to induce an increase in liver glycogen, did not show any hyperglycemia after PPH injection.
The phenylhydrazone of ~-ketoglutaric acid was also tested and found to show a lower hyperglycemic activity than PPH. PPH 550 mg/kg intraperitoneally. 2 glucose 800 mg per animal orally. 3 Data for each group expressed as the mean of the blood glucose (mg/ml of blood) -4-standard deviation, with the number of rats in parentheses.
Discussion
It has been shown in these experiments that pyruvie acid-phenylhydrazone induces a temporary rise of blood sugar levels in rats, lasting a few hours after the injection of the compound. This hyperglycemia due to PPH should be distinguished from permanent hyperglycemias, as for instance those elicited by pancreatectomy or treatment with a!loxan. Other compounds have been shown to cause a temporary rise in blood sugar levels : SIMON et al. [6, 7] described the hyperglycaemie effect of D-mannoheptulose, and Moso~EY and CovA~ [4] that of anti-insulin antibodies. Also thiazide diuretics can give hyperglycemia [2, 9] .
The similarity of the activity of PPH to that of D-mannoheptulose, as well as the inhibition of PPH hyperglycemia by insulin and by tolbutamide [3] , can lead to the assumption that PPH exerts an antagonistic effect on insulin.
That epinephrine can also play a role, is demonstrated by the lack of effect of PPtt in adrenalectomized rats. Further experiments are required to elucidate this point.
PPtI is active as such; the very slight traces of haemolysis observed 51~ hours after the injection are probably due to a limited decomposition of PPH into pyruvate and phenylhydrazine.
PPH and the phenylhydrazones of other keto-acids could prove to be useful tools in the screening of hypoglycemie agents.
